WA
REGN icon

WP Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

WP Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Sell
1,205
-282
-19% -$192K 0.18% 66
2026
Q1 		$1.15M Sell
1,487
-79
-5% -$60.5K 0.3% 50
2025
Q4 		$1.21M Sell
1,566
-434
-22% -$295K 0.3% 49
2025
Q3 		$1.12M Sell
2,000
-96
-5% -$54.3K 0.29% 54
2025
Q2 		$1.1M Buy
2,096
+3
+0.1% +$1.67K 0.3% 51
2025
Q1 		$1.33M Sell
2,093
-138
-6% -$94.9K 0.44% 44
2024
Q4 		$1.59M Sell
2,231
-102
-4% -$85.6K 0.53% 36
2024
Q3 		$2.45M Sell
2,333
-278
-11% -$309K 0.9% 28
2024
Q2 		$2.74M Sell
2,611
-165
-6% -$160K 0.88% 25
2024
Q1 		$2.67M Sell
2,776
-40
-1% -$38K 0.88% 25
2023
Q4 		$2.47M Sell
2,816
-25
-0.9% -$20.6K 0.92% 24
2023
Q3 		$2.34M Sell
2,841
-20
-0.7% -$15.7K 0.97% 24
2023
Q2 		$2.06M Sell
2,861
-92
-3% -$70.9K 0.82% 27
2023
Q1 		$2.43M Hold
2,953
– – 1% 23
2022
Q4 		$2.13M Sell
2,953
-53
-2% -$39.1K 0.95% 27
2022
Q3 		$2.07M Hold
3,006
– – 0.94% 25
2022
Q2 		$1.78M Sell
3,006
-49
-2% -$31.9K 0.77% 30
2022
Q1 		$2.13M Sell
3,055
-110
-3% -$69.6K 0.88% 26
2021
Q4 		$2M Hold
3,165
– – 0.83% 29
2021
Q3 		$1.92M Sell
3,165
-30
-0.9% -$18.6K 0.79% 26
2021
Q2 		$1.78M Buy
3,195
+181
+6% +$91.7K 0.74% 26
2021
Q1 		$1.43M Buy
+3,014
New +$1.47M 0.62% 32

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

WP Advisors's REGN Position: Q2 2026 in Review

WP Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 19% in Q2 2026, selling an estimated $192K and leaving 1,205 shares worth $752K. The position accounts for 0.18% of the portfolio, ranked #66.

WP Advisors first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.74M in Q2 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • WP Advisors held 1,205 shares of Regeneron Pharmaceuticals worth $752K as of Q2 2026.
  • WP Advisors sold 282 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $192K.
  • Regeneron Pharmaceuticals made up 0.18% of WP Advisors's portfolio in Q2 2026, its #66 holding.
  • WP Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • WP Advisors's Regeneron Pharmaceuticals position peaked at $2.74M in Q2 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on WP Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.